Concepedia
Statistics
Publications
193
Citations
14.8K
H-Index
65
Active since
1954
Affiliations
University of Helsinki(Current)
Helsinki University Hospital
University of Turku
Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology
University of Eastern Finland
Mikko Niemi is an author at University of Helsinki specializing in pharmacology, pharmacokinetics, and medicine.
Publications per year
1954–2024
SLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acid
Marja K. Pasanen, Mikko Neuvonen, Pertti J. Neuvonen et al. · Pharmacogenetics and Genomics · 2006 · 464 citations
Pharmacy, Pharmacokinetics, Pharmacology +16
The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1 and Simvastatin-Induced Myopathy: 2014 Update
Laura B. Ramsey, Samuel G. Johnson, Kelly E. Caudle et al. · Clinical Pharmacology & Therapeutics · 2014 · 440 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +14
Different Effects of SLCO1B1 Polymorphism on the Pharmacokinetics of Atorvastatin and Rosuvastatin
Marja K. Pasanen, Hanna Fredrikson, Pertti J. Neuvonen et al. · Clinical Pharmacology & Therapeutics · 2007 · 431 citations
Pharmacy, Pharmacokinetics, Pharmacology +13
High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SLCO1B1)
Mikko Niemi, Elke Schaeffeler, Thomas Lang et al. · Pharmacogenetics · 2004 · 418 citations
Medicine, Pharmacokinetics, Pharmacology +14
ABCG2 Polymorphism Markedly Affects the Pharmacokinetics of Atorvastatin and Rosuvastatin
Jenni E. Keskitalo, Oliver Zolk, Martin F. Fromm et al. · Clinical Pharmacology & Therapeutics · 2009 · 415 citations
Medicine, Pharmacokinetics, Pharmacology +16
1–5 of 193